Merulinic acid C overcomes gentamicin resistance in Enterococcus faecium

Bioorg Chem. 2020 Jul:100:103921. doi: 10.1016/j.bioorg.2020.103921. Epub 2020 May 12.

Abstract

Enterococci are gram-positive, widespread nosocomial pathogens that in recent years have developed resistance to various commonly employed antibiotics. Since finding new infection-control agents based on secondary metabolites from organisms has proved successful for decades, natural products are potentially useful sources of compounds with activity against enterococci. Herein are reported the results of a natural product library screening based on a whole-cell assay against a gram-positive model organism, which led to the isolation of a series of anacardic acids identified by analysis of their spectroscopic data and by chemical derivatizations. Merulinic acid C was identified as the most active anacardic acid derivative obtained against antibiotic-resistant enterococci. Fluorescence microscopy analyses showed that merulinic acid C targets the bacterial membrane without affecting the peptidoglycan and causes rapid cellular ATP leakage from cells. Merulinic acid C was shown to be synergistic with gentamicin against Enterococcus faecium, indicating that this compound could inspire the development of new antibiotic combinations effective against drug-resistant pathogens.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Drug Resistance, Bacterial / drug effects*
  • Drug Synergism
  • Enterococcus faecium / drug effects*
  • Enterococcus faecium / growth & development
  • Enterococcus faecium / metabolism
  • Gentamicins / pharmacology*
  • Gram-Positive Bacterial Infections / drug therapy
  • Gram-Positive Bacterial Infections / microbiology
  • Humans
  • Hydroxybenzoates / pharmacology

Substances

  • Anti-Bacterial Agents
  • Gentamicins
  • Hydroxybenzoates
  • merulinic acids